GLP-3 Retatrutide 10mg/20mg/30mg

Retatrutide is an advanced research peptide being studied for its potential role in metabolic regulation, weight management, and glucose control. It is a triple agonist that targets the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—three critical pathways involved in energy balance and metabolic function.

Research suggests that this triple-receptor activity may contribute to enhanced insulin sensitivity, appetite regulation, and increased energy expenditure, making Retatrutide a significant subject of interest in studies focused on obesity, diabetes, and metabolic health.

This product is provided for research purposes only and is not approved by the FDA for human or veterinary use. This product is not intended to treat, diagnose, prevent or cure any disease. Purchaser/Researcher must abide by and agree to the Terms of Sale and Disclaimer listed.  All sales are FINAL.